Monitoring Blood Flow to Colorectal Liver Metastases Using Angiotensin II
Author Information
Author(s): D.M. Hemingway, W.J. Angerson, J.H. Anderson, J.A. Goldberg, C.S. McArdle, T.G. Cooke
Primary Institution: University Department of Surgery, Glasgow Royal Infirmary, Glasgow, UK.
Hypothesis
Does intraarterial angiotensin II increase blood flow to colorectal liver metastases?
Conclusion
Increased blood flow following angiotensin II infusion may enhance the exposure of tumors to chemotherapy.
Supporting Evidence
- Six patients with small metastases showed significant increases in blood flow after angiotensin II infusion.
- Two out of four patients with large tumors showed no measurable flow response.
- Systolic pressure increased significantly during the infusion, correlating with blood flow changes.
Takeaway
This study looked at how a medicine called angiotensin II can help blood flow to liver tumors, which might help doctors give better treatment.
Methodology
Laser Doppler flowmetry was used to measure blood flow in patients with colorectal liver metastases during angiotensin II infusion.
Limitations
The study does not provide absolute flow values and results may vary based on individual patient conditions.
Participant Demographics
Patients with biopsy-proven colorectal liver metastases, including those with small and large tumors.
Statistical Information
P-Value
0.009
Statistical Significance
p=0.009
Want to read the original?
Access the complete publication on the publisher's website